Back
FirstCash Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
43
FCFS
FirstCash Holdings
Last Price:
105.80
Seasonality Move:
5.01%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
269.53
Seasonality Move:
13.19%
Sell
43
FirstCash Holdings (FCFS)
is a Sell
Is FirstCash Holdings a Buy, Sell or Hold?
- The current FirstCash Holdings [FCFS] share price is $106.08. The Score for FCFS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- FCFS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $273.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCFS Stock Price Chart
What is FirstCash Holdings's stock price today?
-
The FirstCash Holdings share price today is $106.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCFS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $273.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.66 | Sell |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | 145222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (106.93 - 114.69) | Sell |
| Bollinger Bands (100): | (106.88 - 116.96) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 44.14 | Sell |
| Chaikin Money Flow: | 854887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (270.99 - 291.37) | Sell |
| Bollinger Bands (100): | (223 - 289.2) | Buy |
FCFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.59 | Buy |
| 20-day SMA: | 110.12 | Sell |
| 50-day SMA: | 113.99 | Sell |
| 200-day SMA: | 115.58 | Sell |
| 8-day EMA: | 106.33 | Sell |
| 20-day EMA: | 109.15 | Sell |
| 50-day EMA: | 111.92 | Sell |
| 200-day EMA: | 112.39 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 283.39 | Sell |
| 20-day SMA: | 283.12 | Sell |
| 50-day SMA: | 274.41 | Sell |
| 200-day SMA: | 205.7 | Buy |
| 8-day EMA: | 280.46 | Sell |
| 20-day EMA: | 281.6 | Sell |
| 50-day EMA: | 272.95 | Buy |
| 200-day EMA: | 226.73 | Buy |
FirstCash Holdings Earnings Growth & FCFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $1.31 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
FirstCash Holdings Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||